A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30
- PMID: 2178992
- DOI: 10.1016/0028-2243(90)90079-g
A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30
Abstract
The efficacy, cycle-control and tolerance of Microgynon-30, a widely prescribed levonorgestrel containing oral contraceptive, and Femodene, a new oral-contraceptive containing gestodene, were compared in a randomised, double-blind study involving 456 healthy women over a 6 month period. 229 women were allocated to receive Femodene and 227 received Microgynon-30. No differences between the groups in terms of obstetric and gynaecological history, previous contraceptive history, smoking habits, blood-pressure or body weight at admission were observed. No pregnancies were reported in either group, despite tablet-taking errors recorded in 6.3% of the Femodene group and 7.6% of the Microgynon-30 group. Both oral contraceptives were compared in terms of cycle length, intensity of the withdrawal bleed and side effects. Cycle-control was similar in the two groups. However, significantly fewer subjects reported breakthrough bleeding (with or without spotting) in the Femodene group (18% of patients) compared with the Microgynon-30 group (26% of patients). The incidence of absent withdrawal bleeds was 1% or less in both groups and no significant effects on body weight or blood pressure were observed.
Similar articles
-
Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.Contraception. 1994 Jan;49(1):33-46. doi: 10.1016/0010-7824(94)90107-4. Contraception. 1994. PMID: 8137624 Clinical Trial.
-
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.Br J Obstet Gynaecol. 1993 Sep;100(9):832-8. doi: 10.1111/j.1471-0528.1993.tb14309.x. Br J Obstet Gynaecol. 1993. PMID: 8218004 Clinical Trial.
-
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.Curr Med Res Opin. 1983;8(6):395-404. doi: 10.1185/03007998309111745. Curr Med Res Opin. 1983. PMID: 6406157
-
Desogestrel, norgestimate, and gestodene: the newer progestins.Ann Pharmacother. 1995 Jul-Aug;29(7-8):736-42. doi: 10.1177/106002809502907-817. Ann Pharmacother. 1995. PMID: 8520092 Review.
-
Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1556-61. doi: 10.1016/s0002-9378(94)05019-2. Am J Obstet Gynecol. 1994. PMID: 8178906 Review.
Cited by
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2014 Jan 29;2014(1):CD003987. doi: 10.1002/14651858.CD003987.pub5. Cochrane Database Syst Rev. 2014. PMID: 24477630 Free PMC article. Review.
-
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.Drugs. 1995 Aug;50(2):364-95. doi: 10.2165/00003495-199550020-00010. Drugs. 1995. PMID: 8521763 Review.
-
Scare over oral contraceptives. New group will review evidence for effective care in family planning.BMJ. 1995 Dec 16;311(7020):1638. doi: 10.1136/bmj.311.7020.1638a. BMJ. 1995. PMID: 8555817 Free PMC article. No abstract available.
-
Effectiveness and acceptability of progestogens in combined oral contraceptives - a systematic review.Reprod Health. 2004 Jun 3;1(1):1. doi: 10.1186/1742-4755-1-1. Reprod Health. 2004. PMID: 15357865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
